Our most advanced program, VENT-02, a brain-penetrant NLRP3 inhibitor, is in Phase 1.
We are a clinical-stage biopharmaceutical company advancing a pipeline of novel medicines in immunology, inflammation, and neurology.
Central to our ethos is the belief that our employees should be empowered to solve complex problems with bold and innovative solutions.
If you’re up for a journey with an exceptional team pursuing exciting science, please check out our job openings below. We’re always on the lookout for talented people – and we are growing!